Baidu
map

JNNP:蛛网膜下腔出血的不良结局,随时间如何变化?

2021-07-10 Freeman MedSci原创

蛛网膜下腔出血的不良结局,随时间如何变化?

据报道,动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%,在老年人中仍然很高。尽管关于动脉瘤性SAH的结果预测模型已被报道,但据目前还没有可视化工具来帮助临床决策,并通过图形显示年龄与不良结果之间的非线性关系来告知患者及其家属。

发达国家的人口老龄化将给未来社会带来前所未有的负担。根据经济合作与发展组织的数据,日本是全球预期寿命最高的国家。因此,它是一个适合进行高龄影响研究的国家。

已有文献记载,高龄和初始神经状态不佳对通过手术夹闭或血管内钉扎治疗的动脉瘤性SAH患者的结果有不利影响。根据不同的报告,临床阈值年龄为70或75岁。此外,在一些临床领域,年龄和结果之间的相关性被认为是非线性的。

然而,到目前为止,还没有关于动脉瘤性SAH的这种非线性相关性的详细分析和可视化的报道。因此,需要根据动脉瘤性SAH患者的初始神经系统状况,对这种相关性进行可视化的研究作为参考。

藉此,Shimane Prefectural Central Hospital的Fusao Ikawa等人,使用了日本全国范围内的临床注册数据,以可视化的方式显示了根治性动脉瘤SAH患者的年龄和出院时的不良结果之间的非线性相关性。

他们从日本卒中数据库登记处提取了2000年至2017年期间SAH发病后3天内通过手术切除或血管内钉扎治疗的SAH患者数据。出院时修改后的Rankin量表评分≥3分即为不良后果。变量的重要性是用机器学习(随机森林)模型计算的。在调整协变量的情况下,年龄和不良后果之间的相关性是使用广义加性模型(generalised additive
models)确定的。

他们总共纳入4149名患者进行分析。WFNS等级和年龄在预测结果中具有最大和第二大的变量重要性。在调整了其他协变量后,年龄与不良结局之间的非线性相关关系得以显现。

对于I-III级,单位年龄的风险斜率在年轻时相对较小,在年长时较大;对于IV级,斜率即使在年轻时也很陡峭;而对于V级,斜率相对平稳,但即使在年轻时也有高风险。

这个研究的重要意义在于,将年龄与不良结局之间的非线性相关关系清晰地可视化,可以帮助临床决策,帮助动脉瘤性SAH患者及其家属更好地了解情况。

原文出处:
Ikawa F, Ichihara N, Uno M, et al
Visualisation of the non-linear correlation between age and poor outcome in patients with aneurysmal subarachnoid haemorrhage
Journal of Neurology, Neurosurgery & Psychiatry Published Online First: 15 June 2021. doi: 10.1136/jnnp-2020-325306

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654513, encodeId=959d16545137a, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 21 03:15:03 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998158, encodeId=6dcb99815898, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abe25434876, createdName=ms6000000196724174, createdTime=Sat Jul 10 10:28:45 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998127, encodeId=c66d99812efb, content=动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sat Jul 10 07:19:53 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998125, encodeId=c38e998125d9, content=学习打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Sat Jul 10 07:18:02 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654513, encodeId=959d16545137a, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 21 03:15:03 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998158, encodeId=6dcb99815898, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abe25434876, createdName=ms6000000196724174, createdTime=Sat Jul 10 10:28:45 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998127, encodeId=c66d99812efb, content=动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sat Jul 10 07:19:53 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998125, encodeId=c38e998125d9, content=学习打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Sat Jul 10 07:18:02 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 ms6000000196724174

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1654513, encodeId=959d16545137a, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 21 03:15:03 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998158, encodeId=6dcb99815898, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abe25434876, createdName=ms6000000196724174, createdTime=Sat Jul 10 10:28:45 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998127, encodeId=c66d99812efb, content=动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sat Jul 10 07:19:53 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998125, encodeId=c38e998125d9, content=学习打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Sat Jul 10 07:18:02 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 言西早

    动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1654513, encodeId=959d16545137a, content=<a href='/topic/show?id=5ab788e81d3' target=_blank style='color:#2F92EE;'>#蛛网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88781, encryptionId=5ab788e81d3, topicName=蛛网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sat May 21 03:15:03 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998158, encodeId=6dcb99815898, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abe25434876, createdName=ms6000000196724174, createdTime=Sat Jul 10 10:28:45 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998127, encodeId=c66d99812efb, content=动脉瘤性蛛网膜下腔出血(SAH)的病死率约为35%, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Sat Jul 10 07:19:53 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998125, encodeId=c38e998125d9, content=学习打卡, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Sat Jul 10 07:18:02 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 学医无涯

    学习打卡

    0

相关资讯

Lancet:氨甲环酸早期短疗程治疗不能改善蛛网膜下腔出血患者的中短期预后

目前已证明,动脉瘤性蛛网膜下腔出血患者采用氨甲环酸短期抗纤溶治疗可降低再出血的风险。但是,这种治疗是否可以改善临床预后尚不清楚。本研究旨在调查氨甲环酸超早期短疗程治疗是否可以改善6个月内的临床预后。

Stroke:中性粒细胞计数作为预测动脉瘤性蛛网膜下腔出血患者住院死亡率有前景的标志物

在动脉瘤性蛛网膜下腔出血患者中,入院时较高的中性粒细胞计数与死亡率和医院获得性感染风险增加相关。中性粒细胞计数是一个简单、有用的标志物,对动脉瘤性蛛网膜下腔出血患者具有重要的预后价值。

Brain:神经丝轻链蛋白,可有效预测蛛网膜下腔出血的临床预后

神经丝轻链蛋白,可有效预测蛛网膜下腔出血的临床预后

Crit Care Med:动脉瘤性蛛网膜下腔出血患者镁与出血量的关系

由此可见,这些数据支持以下假设:镁可能通过止血机制影响动脉瘤蛛网膜下腔出血患者的出血严重程度。

Stroke:动脉瘤性蛛网膜下腔出血患者通过腰椎导管进行脑脊液过滤的疗效

由此可见,PILLAR治疗动脉瘤性蛛网膜下腔出血的初步尝试具有安全性和可行性,其证明了安全过滤脑脊液和清除血液和血液副产物的潜能。

Stroke:动脉瘤性蛛网膜下腔出血的发生率和结局

近日,心血管疾病领域权威杂志Stroke上发表了一篇研究文章,这项研究旨在评估全国范围内动脉瘤性蛛网膜下腔出血(aSAH)的发生率和结局。瑞士蛛网膜下腔出血研究(SOS)于2008年启动,该研究为了解

Baidu
map
Baidu
map
Baidu
map